Bio-Rad Laboratories (BIO) Tax Provisions (2009 - 2026)

Bio-Rad Laboratories (BIO) has reported Tax Provisions for 18 consecutive years, with $170.7 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Tax Provisions rose 77.44% year-over-year to $170.7 million in Q2 2026; TTM through Jun 2026 was $128.0 million, a 2.22% decrease from a year earlier, with the FY2025 full-year figure at $235.6 million, up 147.28% from the prior year.
• Tax Provisions was $170.7 million for Q2 2026 at Bio-Rad Laboratories, up from -$162.7 million in the prior quarter.
• Over five years, Tax Provisions peaked at $263.6 million in Q4 2022 and troughed at -$1.0 billion in Q1 2022.
• A 5-year average of -$85.8 million and a median of $17.6 million in 2023 frame the typical range for Tax Provisions.
• Across the five-year window, Tax Provisions jumped 575.64% in 2024 and plunged 938.66% in 2026, its largest moves.
• Over 5 years, Tax Provisions stood at $263.6 million in 2022, then tumbled by 70.16% to $78.7 million in 2023, then plunged by 345.47% to -$193.1 million in 2024, then jumped by 208.34% to $209.2 million in 2025, then fell by 18.4% to $170.7 million in 2026.
• The last three Tax Provisions figures came in at $170.7 million (Q2 2026), -$162.7 million (Q1 2026), and $209.2 million (Q4 2025), per Business Quant data.